Revenio Group Oyj (HLSE:REG1V) is looking for M&A opportunities. Robin Pulkkinen, Chief Financial Officer said, "We still continued in searching for the potential M&A opportunities, especially -- and partnerships, especially to expand the ophthalmic diagnostic device market reach and portfolio. We're in a good financial position, and the operating model is really robust, has really served us well and is geared for value creation also in the future".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.22 EUR | +5.70% | +2.27% | -7.14% |
Apr. 25 | Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.14% | 716M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-18.10% | 682M | |
+4.01% | 480M |
- Stock Market
- Equities
- REG1V Stock
- News Revenio Group Oyj
- Revenio Group Seeks M&A Opportunities